Plavsic Mark

Insider profile

Performance

Overall performance
3.1

Performance over holding periods
3.1
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 47% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Plavsic Mark's trades of Aura Biosciences Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-02-17 2026-02-17 PrS Proposed sale
95,895
329.36
US$4,082,200
95,895 329.36 US$4,082,200
2026-02-17 2026-02-17 S Sale
32,239 -41.5%
164.15
US$431,895
32,239 -41.5% 164.15 US$431,895
2025-10-16 2025-10-16 PrS Proposed sale
587
264.98
US$1,612,184
587 264.98 US$1,612,184
2025-10-16 2025-10-16 S Sale
12,169 -5.8%
6.35
US$77,273
12,169 -5.8% 6.35 US$77,273
2025-02-18 2025-02-18 PrS Proposed sale
2,151
7.75
US$16,670
2,151 7.75 US$16,670
2025-02-18 2025-02-18 S Sale
2,151 -1.0%
7.75
US$16,670
2,151 -1.0% 7.75 US$16,670
2024-10-16 2024-10-16 PrS Proposed sale
7,383
9.85
US$72,723
7,383 9.85 US$72,723
2024-10-16 2024-10-16 S Sale
7,383 -5.7%
9.85
US$72,723
7,383 -5.7% 9.85 US$72,723
2023-01-11 2023-01-10 S Sale
3,418 -2.7%
5.24
US$17,910
3,418 -2.7% 5.24 US$17,910
2022-07-06 2022-07-05 S Sale
3,719 -2.8%
24.61
US$91,525
3,719 -2.8% 24.61 US$91,525